Maximus, Inc. (NYSE:MMS - Get Free Report) saw a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 1,270,000 shares, an increase of 64.3% from the October 31st total of 773,200 shares. Based on an average trading volume of 528,200 shares, the days-to-cover ratio is presently 2.4 days. Approximately 2.1% of the company's stock are sold short.
Insider Buying and Selling
In other news, insider Michelle F. Link sold 1,363 shares of the business's stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total value of $126,159.28. Following the completion of the transaction, the insider now directly owns 6,567 shares of the company's stock, valued at approximately $607,841.52. The trade was a 17.19 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 1.40% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently modified their holdings of the company. V Square Quantitative Management LLC acquired a new position in Maximus during the third quarter valued at $25,000. GAMMA Investing LLC boosted its stake in shares of Maximus by 224.5% in the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider's stock worth $29,000 after buying an additional 238 shares during the last quarter. Blue Trust Inc. grew its holdings in Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider's stock worth $33,000 after acquiring an additional 262 shares during the period. Archer Investment Corp raised its position in Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider's stock valued at $69,000 after acquiring an additional 791 shares in the last quarter. Finally, Ariadne Wealth Management LP purchased a new stake in Maximus in the 2nd quarter worth approximately $90,000. 97.21% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research note on Thursday.
View Our Latest Analysis on MMS
Maximus Stock Up 2.8 %
Shares of MMS stock traded up $2.00 during trading hours on Friday, reaching $74.50. 707,093 shares of the company's stock were exchanged, compared to its average volume of 409,477. Maximus has a 1 year low of $71.75 and a 1 year high of $93.97. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The stock has a market cap of $4.49 billion, a PE ratio of 14.50 and a beta of 0.77. The stock's fifty day moving average price is $86.81 and its two-hundred day moving average price is $87.64.
Maximus Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Saturday, November 30th. Shareholders of record on Friday, November 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.61%. Maximus's dividend payout ratio is currently 24.00%.
About Maximus
(
Get Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.